期刊文献+

结直肠癌EGFR和HER2蛋白表达及其基因拷贝数分析 被引量:8

Protein overexpression and gene copy number of EGFR and HER2 in colorectal carcinoma
原文传递
导出
摘要 目的探索结直肠癌 EGFR 和 HER2蛋白表达和基因拷贝数增加的频率,以及蛋白表达与基因拷贝数增加之间的相关性。方法以石蜡包埋组织芯片为材料,分别采用免疫组织化学(EGFR pharmDx^(TM)和 HercepTest^(TM)试剂盒)和荧光原位杂交(FISH,ISI EGFR SpectrumOrange/CEP7SpectrumGreen 探针组合和 Path Vysion^(TM)试剂盒)方法,检测42例中国人结直肠癌 EGFR 和 HER2蛋白表达和基因状态。结果 EGFR 免疫组织化学0者18例、1+者10例、2+者5例、3+者9例;HER2免疫组织化学0者39例、1+者1例、2+者1例、3+者1例。通过 FISH 分析,EGFR 基因拷贝数无明显增高18例(42.9%),其中包括二体性14例(33.3%)、低三体性4例(9.5%);EGFR 基因拷贝数相对增高者24例(57.1%),包括高三体性3例(7.1%)、低多体性9例(21.4%)、高多体性12例(28.6%);本组患者中无 EGFR 基因扩增者。HER2基因拷贝数增加者共4例(9.5%),其中包括基因扩增1例(2.4%)。EGFR 的蛋白表达与基因拷贝数增加无相关性,两指标与肿瘤分化之间也无相关性。HER2免疫组织化学3+和基因扩增结果一致,与乳腺癌相似。结论这组患者中,具有较高的 EGFR 蛋白表达和基因拷贝数增加的比率,但蛋白表达与基因状态之间以及二者与肿瘤分化程度之间都没有相关性;HER2表达和基因拷贝数增加的频率较低。 Objective To investigate the protein expression and gene copy number of EGFR and HER2, and the correlation between the two markers in colorectal carcinomas in Chinese. Method Total 42 samples of paraffin-embedded colorectal carcinomas in tissue microarray format were studied by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for EGFR and HER2 protein expression and gene copy number status, respectively. Results Among 42 cases evaluated, EGFR scores were 0 in 18 cases, 1 + in 10 cases, 2 + in 5 cases and 3 + in 9 cases. HER2 expression was negative in 39 tumors, 1 + in 1 tumor, 2 + in 1 tumor and 3 + in 1 tumor. For FISH assessing EGFR, 18 (42. 9% ) cases showed no apparent copy number changes, including 14 (33.3%) cases of disomy and 4 (9. 5% ) cases of low trisomy, 24 (57. 1% ) cases showed increased gene copy numbers including high trisomy in 3/42 (7.1%), low polysomy in 9/42 (21.4%) and high polysomy in 12/42 (28.6%) cases. Gene amplification of EGFR is not detected. Four of 42 patients (9. 5% ) had increased HER2 gene copy number, including 3 patients with high polysomy and 1 patient with gene amplification. Significant association was not seen between EGFR protein expression and the gene copy number, nor between two markers and tumor differentiation. There was a highly significant concordance between the gene amplification and IHC 3 + for HER2 similar to that of breast cancer. Conclusions Protein expression and/or increased gene copy number of EGFR is common in colorectal carcinomas but unrelated to pathological features in this cohort. HER2 protein overexpression and/or gene amplification are rare.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2007年第7期447-452,共6页 Chinese Journal of Pathology
关键词 结直肠肿瘤 受体 表皮生长因子 基因 ERBB-2 免疫组织化学 原位杂交 荧光 Colorectal neoplasm Receptor, epidermal growth factor Genes, erbB-2 Immunohistochemistry In situ hybridization, fluorescence
  • 相关文献

参考文献26

  • 1Perez-Soler R. HER1/EGFR targeting, refining the strategy. Oncologist, 2004, 9( 1 ):58-67.
  • 2Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin, 2005, 55 ( 1 ) : 10-30.
  • 3Ooi A, Takehana T, Li X, et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol, 2004,17(8) :895-904.
  • 4Cunningham MP, Essapen S, Thomas H, et al. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients. Int J Oncol, 2006, 28(2) :329-335.
  • 5Caruso ML, Valentini AM. Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer. Anficancer Res, 1996, 16(6B) : 3813-3818.
  • 6Al-Kuraya K, Novotny H, Bavi PP, et al. HER2, TOP2A, CCND1, EGFR, And C-MYC oncogene amplification in colorectal cancer. J Clin Pathol, 2006 Aug 2 ; [- Epub ahead of print].
  • 7Petrova D, Jankova R, Yosifova A, et al. Tissue microarray analysis of EGFR gene amplification and gain in Bulgarian patients with eoloreetal cancer. Onkologie, 2006, 29(5 ) : 198-200.
  • 8Nathanson DR, Culliford AT 4th, Shia J, et al. HER 2/neu expression and gene amplification in colon cancer. Int J Cancer, 2003, 105(6) : 796-802.
  • 9Moroni M, Veronese S, Benvenuti S, et al. C, ene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol, 2005,6(5) : 279-286.
  • 10Al-Kuraya K, Schraml P, Sheikh S, et al. Predominance of highgrade pathway in breast cancer development of Middle East women. Mod Pathol, 2005, 18(7) :891-897.

二级参考文献24

  • 1Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high throughput molecular profiling of tumor specimens. Nat Med, 1998,4:844-847.
  • 2Moch H, Kononen T, Kallioniemi OP, et al. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol,2001, 8:14-20.
  • 3Kallioniemi OP. Biochip technologies in cancer research. Ann Med,2001,33:142-147.
  • 4Becich MJ. The role of the pathologist as tissue refiner and data miner: the impact of functional genomics on the modern pathology laboratory and the critical roles of pathology informatics and bioinformatics. Mol Diagn, 2000,5:287-299.
  • 5Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol, 2001,158:1245- 1251.
  • 6Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol, 2000,31:406-414.
  • 7Gillett CE, Springall RJ, Barnes DM, et al. Multiple tissue core arrays in histopathology research: a validation study. J Pathol,2000,192:549-553.
  • 8Van de Vijver MJ. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).Eur J Cancer, 2001, 37Suppl 1: 11-17.
  • 9Ross JS, Gray GS. Targeted therapy for cancer: the HER-2/neu and Herceptin story. Clin Leadersh Manag Rev, 2003, 17:333-340.
  • 10Vogel-C, Cobieigh MA, Tripathy D? et al. First-line, single-agent Herceptin ( R ) ( trastuzumab ) in metastatic breast cancer: a preliminary report. Eur J Cancer, 2001, 37 Suppl 1:25-29.

共引文献81

同被引文献93

引证文献8

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部